Urihk Pharmaceuticals
  • Home
  • About Us
    • Our Team
    • The Urihk Partnership
  • Products
    • Antibiotic
    • Antifungal
    • Antioxidant
    • Immuno modulator
    • Neuro/CNS
  • Services
  • Learn More
    • News
    • Gallery
    • Careers
  • Contact Us
Select Page

Urihk launches its new Anti-infective for the treatment of XDR /MDR Bacteria

Reading Time
Dec 6, 2024
Reading Time
  • Featured
  • Latest in Urihk
  • News
Reading Time
0 min read

You might also Like Articles


September 13 2024 – Celebrated World Sepsis Day, created In-Clinic Sepsis awareness  
Dec 4, 2024

September 13 2024 – Celebrated World Sepsis Day, created In-Clinic Sepsis awareness  

20-8-21 Patient Education video on a Basic Overview of Ischemic stroke by Dr. Rahul Nag. Issued in the public interest by Urihk Pharmaceuticals Pvt Ltd.
Aug 24, 2021

20-8-21 Patient Education video on a Basic Overview of Ischemic stroke by Dr. Rahul Nag. Issued in the public interest by Urihk Pharmaceuticals Pvt Ltd.

19-07-21 Urihk launches new products, expands our product line.
Aug 9, 2021

19-07-21 Urihk launches new products, expands our product line.

ABOUT URIHK

URIHK pharmaceuticals is a wholly owned subsidiary of UREKA Hong Kong Ltd. We are a vertically integrated pharmaceutical company that launches, registers and distributes innovative products in India.
 

SITEMAP

About Us

Services

Products

Careers

Privacy Policy

CONTACT US

602-603, Sai Samarth Business Park,
Deonar, Govandi (East),
Mumbai (400088), India
Phone: +91 22 497 01103 / 43286
Email: [email protected]